GenVec Competitors and Similar CompaniesClear all

GenVec's competitors and similar companies include Dyne Therapeutics, Neurogene and Maze Therapeutics.

	GenVec GenVec is a clinical-stage biopharmaceutical company focusing on developing a pipeline of therapeutics and vaccines through its proprietary AdenoVerse gene delivery platform.	Dyne Therapeutics Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases.	Neurogene Neurogene is a biotechnology company which accelerates the development of genetic medicines to people with devastating neurological diseases.	Maze Therapeutics Maze Therapeutics is a clinical-stage biopharmaceutical company.
Founding Date	Founding Date 1992	Founding Date 2018	Founding Date 2018	Founding Date 2018
Type	Type Subsidiary	Type Public	Type Private	Type Public
Tags	Tags Healthcare Technology biotech genetics pharma platform therapy	Tags Healthcare Technology biotech genetics pharma therapy	Tags Healthcare Technology biotech genetics medtech pharma therapy	Tags Technology biotech drug development genetics pharma platform therapy
Locations	Locations Gaithersburg, US HQ	Locations Waltham, US HQ	Locations New York, US HQ Houston, US	Locations South San Francisco, US HQ Redwood City, US South San Francisco, US
Employees	Employees 27	Employees 1451% decrease	Employees 1091% decrease	Employees 121
Financial
Net income	Net income ($5.8m) (FY, 2016)	Net income ($446.2m) (FY, 2025)	Net income N/A	Net income ($131.1m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 2m	Total funding raised $ 165m	Total funding raised $ 68.5m	Total funding raised $ 191m